TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines
Governed through the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) since 1995, the current medical R&D system requires significant trade-offs between innovation and high monopoly prices for patented drugs that restrict patient access to medic...
Saved in:
Main Authors: | Shiri Mermelstein (Author), Hilde Stevens (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intellectual Property Licensing and Transactions Theory and Practice
by: Contreras, Jorge L.
Published: (2022) -
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis
by: Kyung-Bok Son
Published: (2019) -
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response
by: Tiwadayo Braimoh, et al.
Published: (2024) -
Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
by: Maria Auxiliadora Oliveira, et al. -
The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement
by: Marion Motari, et al.
Published: (2021)